lobbying_activities: 2819165

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2819165	f7f4362f-9174-49ad-84b5-97393936c8ff	Q2	PUBLIC CITIZEN	32362	PUBLIC CITIZEN	2022	second_quarter	PHA	HR 4502-(fy2022 Consolidated Appropriations Act), Covid-19 Vaccine manufacturing, delivery and access and related funding, S 3799 Prevent Pandemics Act (R&D Access conditions, Public MCM manufacturing, Discounted drugs for clinical Trials Act, Pharmaceutical Research and Transparency Act, Generic Substitution Non-Interference Act, drug pricing, FDA-PTO coordination, orange book reform, NDAA licensing access and drug pricing conditions, S 3700-Affordable Insulin Now Act, Drug pricing patent licensing executive Action, Compulsory licensing to lower drug prices, HR 4521-COMPETES Act mandatory drug recall authority provision, HR 7667/ S 4348-User fee legislation, advisory committee and recall provisions, NIH Director position,	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		110000	0	0	2022-07-14T14:21:58-04:00